WFIRM announces successful renewal of its Research Experiences for Undergraduates Site grant

The Wake Forest Institute for Regenerative Medicine (WFIRM) is thrilled to announce the successful renewal of its Research Experiences for Undergraduates (REU) Site grant from the National Science Foundation (NSF).

Brett Favre’s Parkinson’s: ‘Hell, I Wrote the Book on Head Trauma’

Several news items this week put professional football and head trauma back in the spotlight. On Monday, a study showed that one-third of former National

September 28, 2024

Revance to be acquired for $900M+ as Botox trade secrets lawsuit continues

Revance Therapeutics, the maker of Botox competitor Daxxify, will be acquired for more than $900 million. Crown Laboratories will buy out … Sign up to

August 13, 2024

Second Drug OK’d for Ultra-Rare Neurodegenerative Disease

The FDA gave the green light to levacetylleucine (Aqneursa) as a stand-alone treatment for Niemann-Pick disease type C (NPC), just days after approving the first

September 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.